ArticleFrontiers in oncology2025

Ivonescimab for EGFR-mutant lung adenosquamous carcinoma after multiline therapy: A case report.

Xiaohua Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.